Karasoy, HYuceyar, NSirin, HArac, N2019-10-272019-10-2720010960-8966https://hdl.handle.net/11454/35686eninfo:eu-repo/semantics/closedAccesscholesterol lowering agentstoxic myopathyrhabdomyolysisCholesterol lowering agent myopathyConference Object1106.Jul669669WOS:000170822100217Q2